General Information of Disease (ID: DISA9SHW)

Disease Name Febrile seizures, familial, 8
Synonyms
ECA2; Gefs+, type 3; epilepsy, childhood absence, susceptibility to, type 2; susceptibility to childhood absence epilepsy 2; GEFSP3; epilepsy, childhood absence, susceptibility to, 2; childhood absence epilepsy caused by mutation in GABRG2; GABRG2 childhood absence epilepsy; GABRG2 generalised epilepsy with febrile seizures plus; generalized epilepsy with febrile seizures plus, type 3; GABRG2 generalized epilepsy with febrile seizures plus; generalised epilepsy with febrile seizures plus, type 3; generalized epilepsy with febrile seizures plus caused by mutation in GABRG2; generalised epilepsy with febrile seizures plus caused by mutation in GABRG2
Definition
A childhood absence epilepsy that is characterized by mutations in the GABRG2 gene, which cause a spectrum of seizure disorders, ranging from early-onset isolated febrile seizures (FS) to childhood absence epilepsy (CAE) to generalized epilepsy with febrile seizures plus, type 3 (GEFS+3), which tends to represent a more severe phenotype.
Disease Hierarchy
DISJE0UU: Generalized epilepsy with febrile seizures plus
DISZCC8H: Acute repetitive seizure
DIS4709R: Absence seizure
DISA9SHW: Febrile seizures, familial, 8
Disease Identifiers
MONDO ID
MONDO_0011891
UMLS CUI
C1969810
OMIM ID
607681
MedGen ID
370755

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 1 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
GABRG2 TT06RH5 Strong Autosomal dominant [1]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
GABRG2 OTGNDWUO Strong Autosomal dominant [1]
------------------------------------------------------------------------------------

References

1 Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet. 2001 May;28(1):49-52. doi: 10.1038/ng0501-49.